Alternatives to ultrasound for follow-up after medication abortion: a systematic review

被引:59
作者
Grossman, Daniel [1 ]
Grindlay, Kate [1 ]
机构
[1] Ibis Reprod Hlth, Oakland, CA 94612 USA
关键词
Abortion; Induced; Aftercare; Female; Follow-up studies; Humans; Pregnancy; Pregnancy trimester; First; EARLY-PREGNANCY; UNITED-STATES; SERUM HCG; CHORIONIC-GONADOTROPIN; VAGINAL MISOPROSTOL; MIFEPRISTONE; TERMINATION; METHOTREXATE; EFFICACY; SERVICES;
D O I
10.1016/j.contraception.2010.08.023
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Requiring a follow-up visit with ultrasound evaluation to confirm completion after medication abortion can be a barrier to providing the service. Study Design: The PubMed (including MEDLINE), Cochrane Central Register of Controlled Trials and POPLINE databases were systematically searched in October and November 2009 for studies related to alternative follow-up modalities after first-trimester medication abortion to diagnose ongoing pregnancy or retained gestational sac. We calculated the sensitivity, specificity, positive predictive value and negative predictive value compared with ultrasound or clinician's exam. We also calculated the proportion of cases in each study with a positive screening test. Results: Our search identified eight articles. The most promising modalities included serum human chorionic gonadotropin measurements, standardized assessment of women's symptoms combined with low-sensitivity urine pregnancy testing and telephone consultation. These follow-up modalities had sensitivities >= 90%, negative predictive values >= 99% and proportions of "screen-positives" >= 33%. Conclusions: Alternatives to routine in-person follow-up visits after medication abortion are accurate at diagnosing ongoing pregnancy. Additional research is needed to demonstrate the accuracy, acceptability and feasibility of alternative follow-up modalities in practice, particularly of home-based urine testing combined with self-assessment and/or clinician-assisted assessment. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:504 / 510
页数:7
相关论文
共 35 条
[1]  
[Anonymous], CLIN POL GUID
[2]  
[Anonymous], OBSTET GYNECOL
[3]  
[Anonymous], 2003, Safe abortion: Technical and policy guidance for health systems
[4]   Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost [J].
Bartley, J ;
Tong, S ;
Everington, D ;
Baird, DT .
CONTRACEPTION, 2000, 62 (06) :297-303
[5]   Medication abortion employing routine sequential measurements of serum hCG and sonography only when indicated [J].
Clark, Wesley ;
Panton, Tanya ;
Hann, Louisa ;
Gold, Marji .
CONTRACEPTION, 2007, 75 (02) :131-135
[6]   Alternatives to a Routine Follow-Up Visit for Early Medical Abortion [J].
Clark, Wesley ;
Bracken, Hillary ;
Tanenhaus, Jini ;
Schweikert, Suzanne ;
Lichtenberg, E. Steve ;
Winikoff, Beverly .
OBSTETRICS AND GYNECOLOGY, 2010, 115 (02) :264-272
[7]   Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research [J].
Clark, Wesley H. ;
Gold, Maiji ;
Grossman, Daniel ;
Winikoff, Beverly .
CONTRACEPTION, 2007, 75 (04) :245-250
[8]  
CREININ M, 2009, MANAGEMENT UNINTENDE, P125
[9]   Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol [J].
Creinin, MD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (02) :776-778
[10]   Methotrexate and misoprostol for early abortion: A multicenter trial .1. Safety and efficacy [J].
Creinin, MD ;
Vittinghoff, E ;
Keder, L ;
Darney, PD ;
Tiller, G .
CONTRACEPTION, 1996, 53 (06) :321-327